CA2319765A1 - New contraceptive kit - Google Patents

New contraceptive kit Download PDF

Info

Publication number
CA2319765A1
CA2319765A1 CA002319765A CA2319765A CA2319765A1 CA 2319765 A1 CA2319765 A1 CA 2319765A1 CA 002319765 A CA002319765 A CA 002319765A CA 2319765 A CA2319765 A CA 2319765A CA 2319765 A1 CA2319765 A1 CA 2319765A1
Authority
CA
Canada
Prior art keywords
contraceptive
structural formula
steroid compound
pharmaceutically acceptable
steroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002319765A
Other languages
English (en)
French (fr)
Inventor
Helenius Jan Kloosterboer
Godefridus Hermanus Johanna Deckers
Johannes Antonius Maria Hamersma
Pieter Michiel Verbost
Herman Jan Tijmen Coelingh Bennink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2319765A1 publication Critical patent/CA2319765A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
CA002319765A 1998-03-09 1999-03-03 New contraceptive kit Abandoned CA2319765A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98200744 1998-03-09
EP98200744.5 1998-03-09
PCT/EP1999/001404 WO1999045886A2 (en) 1998-03-09 1999-03-03 New contraceptive kit for monotherapy

Publications (1)

Publication Number Publication Date
CA2319765A1 true CA2319765A1 (en) 1999-09-16

Family

ID=8233452

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002319765A Abandoned CA2319765A1 (en) 1998-03-09 1999-03-03 New contraceptive kit

Country Status (20)

Country Link
EP (1) EP1061928A2 (de)
JP (1) JP2002506014A (de)
KR (1) KR20010041698A (de)
CN (1) CN1292702A (de)
AR (1) AR018313A1 (de)
AU (1) AU756882B2 (de)
BR (1) BR9908605A (de)
CA (1) CA2319765A1 (de)
CO (1) CO5070598A1 (de)
HU (1) HUP0101007A3 (de)
ID (1) ID25621A (de)
IL (1) IL137541A0 (de)
NO (1) NO20004492L (de)
NZ (1) NZ506115A (de)
PE (1) PE20000330A1 (de)
PL (1) PL343428A1 (de)
RU (1) RU2225714C2 (de)
TR (1) TR200002593T2 (de)
WO (1) WO1999045886A2 (de)
ZA (1) ZA991851B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999051214A2 (en) * 1998-04-07 1999-10-14 Akzo Nobel N.V. Progestogen-only contraceptive kit
MXPA02001831A (es) * 1999-09-06 2002-10-23 Akzo Nobel Nv Esteroides estrogenicos no aromaticos con un sustituyente de hidrocarburo en posicion 11.
BR0112791A (pt) 2000-07-28 2003-06-24 Akzo Nobel Nv Composto esteroidal 16alfa-substituido, uso do mesmo, métodos de tratamento para ativação seletiva de receptores de estrogênio do subtipo alfa, e para terapia de reposição hormonal ou contracepção, e, composição farmacêutica
WO2003077925A1 (en) * 2002-03-11 2003-09-25 Janssen Pharmaceutica N.V. Sulfatase inhibiting continuous progestogen contraceptive regimens
WO2003077927A1 (en) * 2002-03-11 2003-09-25 Janssen Pharmaceutica N.V. Sulfatase inhibiting progestogen-only contraceptive regimens
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7701384A (nl) * 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints

Also Published As

Publication number Publication date
AR018313A1 (es) 2001-11-14
BR9908605A (pt) 2001-04-24
CN1292702A (zh) 2001-04-25
KR20010041698A (ko) 2001-05-25
ID25621A (id) 2000-10-19
WO1999045886A3 (en) 1999-12-02
HUP0101007A3 (en) 2002-02-28
PE20000330A1 (es) 2000-05-16
PL343428A1 (en) 2001-08-13
AU756882B2 (en) 2003-01-23
EP1061928A2 (de) 2000-12-27
IL137541A0 (en) 2001-07-24
AU3143799A (en) 1999-09-27
HUP0101007A2 (hu) 2001-12-28
WO1999045886A2 (en) 1999-09-16
TR200002593T2 (tr) 2000-12-21
NO20004492D0 (no) 2000-09-08
RU2225714C2 (ru) 2004-03-20
JP2002506014A (ja) 2002-02-26
NO20004492L (no) 2000-09-08
ZA991851B (en) 1999-09-22
CO5070598A1 (es) 2001-08-28
NZ506115A (en) 2003-07-25

Similar Documents

Publication Publication Date Title
JP4023820B2 (ja) エストラ−１，３，５（１０）−トリエン誘導体を含有する医薬製剤
RU2166509C2 (ru) Производные 19-норпрегнена, фармацевтическая композиция, соединения
JP3814292B2 (ja) エストラ−１，３，５（１０）−トリエン誘導体、これらの製造方法及びこれら化合物を含有する製薬組成物
CZ290612B6 (cs) Antikoncepční činidlo a sloučeniny pro antikoncepci
EP0912186A1 (de) Progestogen-anti-progestogen therapien
EP0785211A1 (de) Neue substituierte 19-nor-Pregnan-Derivate
US4027019A (en) 3-Oximes of D-17α-ethynyl-19-nortestosterone esters and method
AU756882B2 (en) New contraceptive kit
CA2384184C (en) 17.beta.-acyl-17.alpha.-propynyl-11.beta.-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties
JP2007210994A (ja) ステロイド類、それらの調製、それらの薬学的組成物およびこの化合物の使用
IE872217L (en) 14,17-beta-ethano-14-beta-estratrienes and estratetraenes
CA2309745A1 (en) Progestogen-antiprogestogen regimens
MXPA00008814A (en) New contraceptive kit
WO1999051214A2 (en) Progestogen-only contraceptive kit
CZ20003285A3 (cs) Antikoncepční sada
US3816406A (en) O-aryl oximes of 3-keto steroids
US3644330A (en) Derivatives of estradiol-17beta-glucosides
AU708135C (en) New 19-nor-pregnene derivatives

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued